[go: up one dir, main page]

MX2016013280A - Composiciones topicas para el alivio del dolor, manufactura y uso. - Google Patents

Composiciones topicas para el alivio del dolor, manufactura y uso.

Info

Publication number
MX2016013280A
MX2016013280A MX2016013280A MX2016013280A MX2016013280A MX 2016013280 A MX2016013280 A MX 2016013280A MX 2016013280 A MX2016013280 A MX 2016013280A MX 2016013280 A MX2016013280 A MX 2016013280A MX 2016013280 A MX2016013280 A MX 2016013280A
Authority
MX
Mexico
Prior art keywords
pain relief
manufacture
topical compositions
compositions
methods
Prior art date
Application number
MX2016013280A
Other languages
English (en)
Other versions
MX377377B (es
Inventor
Daniel Bucks
J Birbara Philip
Original Assignee
Vizuri Health Sciences Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vizuri Health Sciences Llc filed Critical Vizuri Health Sciences Llc
Publication of MX2016013280A publication Critical patent/MX2016013280A/es
Publication of MX377377B publication Critical patent/MX377377B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125—Camphor; Nuclear substituted derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a composiciones agonistas selectivas de TRPV1 que incluyen un capsaicinoide, un surfactante y un agente de liberación prolongada, y a métodos de manufactura y métodos para proporcionar alivio del dolor así como también para tratar una variedad de trastornos con estas composiciones.
MX2016013280A 2014-04-15 2015-04-15 Composiciones tópicas para el alivio del dolor, manufactura y uso. MX377377B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461979905P 2014-04-15 2014-04-15
PCT/US2015/025957 WO2015160941A1 (en) 2014-04-15 2015-04-15 Topical compositions for pain relief, manufacture and use

Publications (2)

Publication Number Publication Date
MX2016013280A true MX2016013280A (es) 2017-04-27
MX377377B MX377377B (es) 2025-03-10

Family

ID=53008908

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016013280A MX377377B (es) 2014-04-15 2015-04-15 Composiciones tópicas para el alivio del dolor, manufactura y uso.

Country Status (9)

Country Link
US (6) US9956190B2 (es)
EP (1) EP3131531B1 (es)
JP (1) JP6563954B2 (es)
KR (1) KR102073258B1 (es)
AU (1) AU2015247649B2 (es)
BR (1) BR112016023815A2 (es)
CA (1) CA2945818C (es)
MX (1) MX377377B (es)
WO (1) WO2015160941A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10265283B2 (en) 2012-12-07 2019-04-23 Sambria Pharmaceuticals, Llc Topical composition and delivery system and its use
GB2525517B (en) 2012-12-07 2019-12-04 Sambria Pharmaceuticals Llc Topical preparation for pain relief
JP6563954B2 (ja) 2014-04-15 2019-08-21 ヴィズリ・ヘルス・サイエンスィズ・エルエルシー 痛みの緩和のための局所組成物、製造および使用
WO2017135948A1 (en) * 2016-02-03 2017-08-10 Greenspan Michael H Topical composition and delivery system and its use
JP7100635B2 (ja) 2016-11-02 2022-07-13 セントレクシオン セラピューティクス コーポレイション 安定な水性カプサイシン注射製剤およびその医学的使用
MX389336B (es) 2016-11-15 2025-03-20 Klaria Pharma Holding Ab Formulacion farmaceutica.
US10918685B2 (en) * 2017-01-05 2021-02-16 Ravi Ramamoorthy Iyer Herbal topical composition for muscle and joint health, recovery from exertion, and for pain management
GB201709141D0 (en) 2017-06-08 2017-07-26 Klaria Pharma Holding Ab Pharmaceutical formulation
ES3018268T3 (en) 2017-07-20 2025-05-14 Centrexion Therapeutics Corp Compositions and their use for treatment of pain using capsaicin
GB201808462D0 (en) 2018-05-23 2018-07-11 Klaria Pharma Holding Ab Pharmaceutical formulation
US11447444B1 (en) 2019-01-18 2022-09-20 Centrexion Therapeutics Corporation Capsaicinoid prodrug compounds and their use in treating medical conditions
US11254659B1 (en) 2019-01-18 2022-02-22 Centrexion Therapeutics Corporation Capsaicinoid prodrug compounds and their use in treating medical conditions
JP2020152674A (ja) * 2019-03-20 2020-09-24 株式会社リコー 難水溶性化合物の可溶化物の製造方法
AU2021238637B2 (en) 2020-03-17 2025-12-18 Grünenthal GmbH Repeated topical application of capsaicin patch for treating initial non-responders
JP2023520024A (ja) 2020-04-03 2023-05-15 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング カプサイシンパッチの繰り返しの局所適用のためのレジメン
US12268663B2 (en) * 2020-10-03 2025-04-08 Pruvyc Pharma, LLC Method for treating pruritus
EP4447935A1 (en) 2021-12-17 2024-10-23 Aerie Pharmaceuticals, Inc. Ophthalmic pharmaceutical compositions and uses thereof
KR102567166B1 (ko) * 2022-01-18 2023-08-18 주식회사 네오메디컬 스틱형 파스
WO2025153517A1 (en) 2024-01-15 2025-07-24 Grünenthal GmbH Treating knee joint pain by injecting resiniferatoxin at ultra low doses
KR102897643B1 (ko) * 2025-10-10 2025-12-10 유한회사 위너 찜질용 온열 크림 조성물 및 그 조성물을 이용한 찜질방법

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486450B1 (en) 1980-07-14 1998-07-28 Joel E Bernstein Method of treating psoriatic skin and composition
US4424205A (en) 1982-03-18 1984-01-03 The Procter & Gamble Company Hydroxyphenylacetamides having analgesic and anti-irritant activity
US5134166A (en) 1988-12-02 1992-07-28 Genderm Corporation Method for treating nasal disorders and headaches
US4997853A (en) 1988-12-02 1991-03-05 Galenpharma, Inc. Method and compositions utilizing capsaicin as an external analgesic
US5178879A (en) * 1992-04-17 1993-01-12 Michael Adekunle Capsaicin gel
US5910512A (en) 1994-04-18 1999-06-08 Healthline Laboratories, Inc. Topical analgesic using water soluble capsaicin
US5560910A (en) 1994-08-26 1996-10-01 Crandall; Wilson T. Topical anti-inflammatory composition and method
US6239180B1 (en) 1995-11-08 2001-05-29 The Regents Of The University Of California Transdermal therapeutic device and method with capsaicin and capsaicin analogs
DK1201241T3 (da) 1997-03-13 2010-12-13 James N Campbell Sammensætninger indeholdende capsaicin eller capsaicinanaloge og et bedøvelsesmiddel
JP3211027B2 (ja) 1998-11-13 2001-09-25 丸石製薬株式会社 カプサイシン含有外用剤
US6573302B1 (en) 1999-09-29 2003-06-03 Medical Merchandising, Inc. Cream utilizing capsaicin
US6348501B1 (en) 1999-09-29 2002-02-19 Medical Merchandising, Inc. Lotion compositions utilizing capsaicin
US6689399B1 (en) 2000-03-16 2004-02-10 James R. Dickson Transdermal delivery of an anti-inflammatory composition
EP1605956B1 (en) 2002-12-18 2015-11-11 Centrexion Therapeutics Corporation Administration of capsaicinoids for the treatment of osteoarthritis
EP1610742B1 (en) * 2003-04-10 2015-01-21 Neurogesx, Inc. Uses and compositions for administration of capsaicin
WO2005117981A1 (en) 2004-06-02 2005-12-15 Sri International Formulations comprising a capsaicinoid a local anesthetic and/or an antipruritic agent for the treatment of pain
US20060148903A1 (en) 2004-11-24 2006-07-06 Algorx Pharmaceuticals, Inc. Capsaicinoid gel formulation and uses thereof
PL1830835T3 (pl) * 2004-12-28 2012-08-31 Mestex Ag Zastosowanie agonisty receptorów waniloidowych razem z glikozaminoglikanem albo proteoglikanem do wytwarzania środka do leczenia bólów stawów i sposób stosowania tego środka
ES2353399T3 (es) 2005-04-01 2011-03-01 Neurogesx, Inc. Aceites de capsaicinoides y métodos para obtenerlos y usarlos.
MX2007013330A (es) 2005-04-25 2008-01-18 Neurogesx Inc Compuestos agonistas de trpv1 y metodos para hacer y usar los mismos.
ATE551992T1 (de) 2005-05-27 2012-04-15 Royer Biomedical Inc Bioresorbierbare polymermatrizes und verfahren zu ihrer herstellung und verwendung
JP5066342B2 (ja) * 2006-04-28 2012-11-07 キユーピー株式会社 新規なヒアルロン酸および／またはその塩、ならびにこれを用いた化粧料、医薬組成物、食品組成物、および化粧料キット
US7282224B1 (en) * 2006-06-09 2007-10-16 Guthy-Renker Corporation Pain relief composition
US7943666B2 (en) 2006-07-24 2011-05-17 Trinity Laboratories, Inc. Esters of capsaicin for treating pain
US8637569B2 (en) 2009-10-22 2014-01-28 Api Genesis, Llc Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds
EP2316420B1 (en) * 2009-10-22 2014-02-26 Consorzio Universitario Unifarm Topical ophthalmic composition to reduce pain
WO2011057387A1 (en) * 2009-11-13 2011-05-19 Oral Delivery Technology Ltd . Nitric oxide amino acid esters for the treatment of chronic pain
EP2455066B1 (en) 2010-11-08 2018-10-17 EPITECH GROUP S.p.A. Pharmacological preparation for topical use containing N-palmitoyl-vanillamide
US8889659B2 (en) * 2011-09-09 2014-11-18 Api Genesis, Llc Pain relief compositions, manufacture and uses
AU2013341380B2 (en) * 2012-11-12 2018-04-26 Propella Therapeutics, Inc. Aqueous based capsaicinoid formulations, and treatment in combination with a corticosteroid
JP6563954B2 (ja) 2014-04-15 2019-08-21 ヴィズリ・ヘルス・サイエンスィズ・エルエルシー 痛みの緩和のための局所組成物、製造および使用

Also Published As

Publication number Publication date
KR20160145628A (ko) 2016-12-20
CA2945818A1 (en) 2015-10-22
US20200323800A1 (en) 2020-10-15
US20180214398A1 (en) 2018-08-02
US20150290151A1 (en) 2015-10-15
US10206892B2 (en) 2019-02-19
KR102073258B1 (ko) 2020-02-04
EP3131531B1 (en) 2022-04-06
JP2017511366A (ja) 2017-04-20
US9956190B2 (en) 2018-05-01
WO2015160941A1 (en) 2015-10-22
JP6563954B2 (ja) 2019-08-21
US20180214397A1 (en) 2018-08-02
US10085956B2 (en) 2018-10-02
AU2015247649B2 (en) 2019-01-17
US10583100B2 (en) 2020-03-10
US20190247337A1 (en) 2019-08-15
AU2015247649A1 (en) 2016-11-03
CA2945818C (en) 2022-05-03
US20220168247A1 (en) 2022-06-02
MX377377B (es) 2025-03-10
US11737994B2 (en) 2023-08-29
EP3131531A1 (en) 2017-02-22
BR112016023815A2 (pt) 2017-08-15
US11123315B2 (en) 2021-09-21

Similar Documents

Publication Publication Date Title
MX2016013280A (es) Composiciones topicas para el alivio del dolor, manufactura y uso.
MX347902B (es) Composicion para el alivio del dolor, que comprende un agonista selectivo de trpv1, y manufactura y usos de la misma.
NI201600071A (es) Compuestos de inhibidor de autotaxina
ECSP16081503A (es) Moléculas de anticuerpo que se unen a lag-3 y usos de las mismas
CL2017003089A1 (es) Formas de dosificación sólidas de palbociclib
CR20150376A (es) Compuestos sustituidos de pirrolopirimidina, compuestos de los mismos y metodos de tratamiento con los mismos
MX2018013472A (es) Tratamiento de combinacion de trastornos y enfermedades inflamatorios oculares.
UY34750A (es) ?compuestos para el tratamiento del hiv, composiciones,métodos de preparación, intermediarios y métodos terapéuticos?.
CL2017003456A1 (es) Metodos para tratar tumores de celulas epitelioides
MX2017015990A (es) Composiciones topicas que comprenden un corticosteroide y un retinoide para tratar psoriasis.
MX2019009783A (es) Metodo para fabricar una barra que comprende antitranspirante.
EA201691808A1 (ru) Кортикостероидные композиции для местного применения
NI201600070A (es) Inhibidores tetracíclicos de autotaxina
CL2018001298A1 (es) Un proceso para preparar una formulación en polvo seco que comprende un anticolinérgico, un corticosteroide y un beta-adrenérgico
MX2021007899A (es) Composiciones con inhibidor selectivo de la trans-se?alizacion de il-6.
DOP2017000146A (es) Pirazolpiridinaminas como inhibidores de mknk1 y mknk2
CO2018007237A2 (es) Reguladores del cftr y métodos para su uso
MX375318B (es) Formas de dosificación y usos terapéuticos de l-4-cloro quinurenina..
LT3229790T (lt) Kompozicijos, apimančios vidutinės grandinės trigliceridus, skirtos panaudoti epilepsijos gydyme
UY35823A (es) Profármacos de antagonista de nmda
CL2015003460A1 (es) Composiciones oftálmicas acuosas tópicas que contienen un derivado de 1h-indol-1-carboxamida y uso de estas para el tratamiento de una enfermedad oftálmica
CL2018001716A1 (es) Reguladores del cftr y métodos para su uso
CL2020000586A1 (es) Moduladores de la expresión de enac.
MX394670B (es) Agentes anticancerigenos y preparacion de los mismos.
MX2016010967A (es) Nuevas composiciones para tratar lesiones neuronales mecanicas.

Legal Events

Date Code Title Description
FG Grant or registration
PD Change of proprietorship

Owner name: PROPELLA THERAPEUTICS, INC.